πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 1,157 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8907060

Mutated Pseudomonas exotoxins with reduced antigenicity

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8900599

Conjugates of Plasmodium falciparum surface proteins as malaria vaccines

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8883448

Mutated ras peptides for generation of CD8+ cytotoxic T lymphocytes

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8877914

Compositions comprising nucleic acids encoding HIV-1 reverse transcriptase CTL epitopes

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Nov 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8871906

Deletions in domain II of pseudomonas exotoxin a that remove immunogenic epitopes

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8871902

Immunogenic POTE peptides and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8871789

Method of preventing or treating viral infection

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8871206

Anti-human folate receptor beta antibodies and methods of use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8865672

Prevention of tissue ischemia and related methods

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8859207

Pharmaceutical compositions which inhibit FKBP52-mediated regulation of androgen receptor

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8858938

Human monoclonal antibodies against Hendra and Nipah viruses

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8859585

Scopolamine for the treatment of depression and anxiety

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 14 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 09 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8853160

GLP-1, exendin-4, peptide analogs and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8853277

Nitroxide therapy for the treatment of von Hippelβ€”Lindau disease (VHL) and renal clear cel

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8846389

AAV4 vector and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 30 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 25 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8841305

Activators of the human pyruvate kinase M2 receptor

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 23 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8835613

Ξ²-mannosylceramide and stimulation of NKT cell anti-tumor immunity

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8828380

Method for the treatment of pulmonary disease and method of producing proteins of use ther

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8828936

Therapeutic use of SCGB3A2

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 09 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 04 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822196

Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of s

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822540

Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8822434

Compositions and methods to treat cardiac diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8821866

Methods of treating and preventing colitis involving IL-13 and NK-T cells

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Sep 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 28 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8815229

Granulysin in immunotherapy

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted